In addition, in the TCGA GBM patient database, the mutation status of the NF1 gene also affected the relationship between ARID1A expression and patient prognosis: the lower the ARID1A expression level in patients with NF1 mutations, the worse the survival of the patients (p = 0.0208) (Figure 2B). Here, NF1 is linked to glioblastoma.